GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 74 weeks, 23kg, and GIP was the hard part — 55 comments in the full submission. View in context.
6.3k
c/tirzepatide·submitted 10 months ago by u/ewan_marchand

[Results] 74 weeks, 23kg, and GIP was the hard part

Resultsbranch of 8 comments

Here it is: 74 weeks, 23kg, and GIP was the hard part. One person, one log, no control group, so read it accordingly. 74 weeks and 23kg. Those are measured, not estimated, and not rounded up in my favour. 8kg over 21 weeks, never went past 10mg, and muscle cramps stayed mild the whole way. Posting because the loud…

Read the full submission and all 55 comments →

This branch

8 comments, started 10 months ago
u/emil_barros773 points·10 months ago·edited

Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.

replysharereportpermalink
u/ewan_marchandOP438 points·10 months ago

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

replysharereportpermalink
u/signe_villalobos415 points·10 months ago

Are you comparing yourself with the trial mean or with the people who post the most?

replysharereportpermalink
[removed]152 points·10 months ago

[removed by moderator]

replysharereportpermalink
u/customs_seizure_sid335 points·10 months ago

What is the waist doing? That is usually the number still moving during a scale stall.

replysharereportpermalink
u/ignacio_vanhecke95 points·10 months ago

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →